期刊
VACCINE
卷 27, 期 -, 页码 B30-B41出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2009.05.003
关键词
Serogroup ACYW135 meningococcus; Neisseria menigitidis; Conjugate vaccines
资金
- Oxford Partnership Comprehensive Biomedical Research Centre Programme
- Department of Health's NIHR Biomedical Research Centres
Neisseria meningitidis is an important cause of bacterial meningitis and septicaemia with most disease caused by meningococci bearing serogroups A, B, C, Y and W-135 polysaccharides. Monovalent serogroup C conjugate vaccines have become established in the immunisation programmes in many countries and the first quadrivalent meningococcal vaccine, containing the polysaccharides from 4 of the serogroups A, C, Y and W-135 meningococci conjugated to a protein carrier was licensed in the US in 2005. This vaccine and others in development offer the potential to broaden population protection against meningococcal disease. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据